[videojs dailymotion =”https://www.dailymotion.com/video/xnynr3″]
Novo Nordisk announced today that the company will establish a type 1 diabetes R&D center in Seattle, US. The new center will combine Novo Nordisk’s history of innovation and leadership in diabetes.